News | October 13, 2025
Cadila launches allergy relief tablet Dlorfast-M
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
Element5’s Agentic AI platform will be integrated with the HCHB EHR
Guidelines aim to establish state-regulated veterinary blood banks
The collaboration will combine Firstsource’s AI-first approach with Guidehealth’s expertise in value-based care innovation
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
The audit has been concluded with no major observations
25 women students to receive internship, training, and mentorship in Life Sciences segment
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
he inspection covering the sterile drug product filling and packaging line, quality systems and quality control laboratories concluded compliance with the principles and guidelines of Good Manufacturing Practice
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
Subscribe To Our Newsletter & Stay Updated
